A Randomized Trial of Itraconazole in Allergic Bronchopulmonary Aspergillosis

A. Stevens, David; J. Schwartz, Howard; Y. Lee, Jeannette; L. Moskovitz, Bruce; C. Jerome, Dennis; Catanzaro, Antonino; M. Bamberger, David; Weinmann, Allison; U. Tuazon, Carmelita; A. Judson, Marc; A.E. Platts‐Mills, Thomas; Grossman, Jay; G. Slavin, Raymond; D. Reuman, Peter; C. DeGraff, Arthur

doi:10.1056/nejm200003163421102

Public

A Randomized Trial of Itraconazole in Allergic Bronchopulmonary Aspergillosis

Published in New England Journal of Medicine • Mar 16, 2000

Authors:

David A. Stevens

Howard J. Schwartz

Jeannette Y. Lee

Abstract

BACKGROUND: Allergic bronchopulmonary aspergillosis is a hypersensitivity disorder that can progress from an acute phase to chronic disease. The main treatment is systemic corticosteroids, but data from uncontrolled studies suggest that itraconazole, an orally administered antifungal agent, may be a...

Subject

Itraconazole

Allergic bronchopulmonary aspergillosis

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!